CMM Treatment ApS: Financial statements 2023
CVR: 38553038
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
CMM Treatment ApS (CVR 38553038) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -8,000 and a net result of DKK -15,766 compared with DKK -6,045 the year before. Equity in the 2023 report amounted to DKK 11,030. The solvency ratio was 68.8%.
- Gross Profit
- DKK -8,000
- Profit/Loss
- DKK -15,766
- Equity
- DKK 11,030
- Total Assets
- DKK 16,030
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -8K | -16K | 11K | 0 |
| 2022 | - | -8K | -6K | 27K | 0 |
| 2021 | - | -8K | -6K | 13K | 0 |
| 2020 | - | -8K | -6K | 19K | 0 |
| 2019 | - | -8K | -6K | 25K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout CMM Treatment ApS
CMM Treatment ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named CMM Treatment IVS. The management consists of Thomas Frilund Jacobsen. The company's owners include Marina Jacobsen, Martin Vetling and Claus Vetling. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -8,500 and a net result of DKK -8,500 compared with DKK -8,250 the year before. Equity in the 2025 report amounted to DKK -5,720.